Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Mon...( NEW YORK March 28 /Xinhua-- Tiens...)

NEW YORK, March 28 /Xinhua-PRNewswire/ -- Tiens Biotech Group (USA), Inc. ("the Company" or "Tiens"), (AMEX: TBV), http://www.tiens-bio.com , announced financial results for the fourth quarter and twelve months ended December 31, 2007.

Revenue for the fourth quarter of 2007 was $13.3 million compared to $16.6 million for the fourth quarter of 2006.

Net income for the fourth quarter of 2007 was $3.9 million, or $0.05 per share, compared to net income of $5.9 million, or $0.08 per share for the fourth quarter of 2006.

Revenue for the twelve months ended December 31, 2007 was $54.9 million, compared to $66.8 million for the twelve months ended December 31, 2006.

Net income for the twelve months ended December 31, 2007 was $18.6 million, or $0.26 per share, compared to $26.3 million, or $0.37 per share for the twelve months ended December 31, 2006.

Revenue by Region

For the fourth quarter of 2007, revenue in China was $6.7 million compared to $6.8 million for the fourth quarter of 2006. For the twelve months ended December 31, 2007, revenue in China was $22.5 million, compared to $27.1 million for the twelve months ended December 31, 2006.

Revenue for 2006 benefited from a special promotion conducted in the third quarter of the year for distributors in China, which increased sales. No similar promotion was held during 2007, which contributed to the decrease in revenue for the period. In addition, the application for a direct selling license in China is still pending. Until the application is approved, Tianshi Engineering will continue to sell Tiens' products through its branches, affiliated companies and chain stores in China.

For the f
'/>"/>